Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Who was against Ottesson filling the last seat at PDS again? - ptsc3p0

Okay, rereading my original reply to you, I do note that I did say "So you're suggesting that it would more wise to "grant" all creditors with 1% of PDS, thus giving PTSC a controlling interest (since PTSC is a creditor)?". (Bolding added).

So a wacky interpretation of my use of the word "all" could imply as you suggest IF you ignore the rest of my post, and ignore the fact that TPL has so many creditors that there probably wouldn't be enough "1%s" to go around.

Sheesh! Definitely done with you... LOL

SGE

Share
New Message
Please login to post a reply